Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37326 - 37350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	GNAS	2778	upregulated	entinostat results in increased expression of GNAS mRNA	20q13.32	A21037
Entinostat	Investigational	GNG2	54331	downregulated	entinostat results in decreased expression of GNG2 mRNA	14q22.1	A21037
Entinostat	Investigational	GNG7	2788	upregulated	entinostat results in increased expression of GNG7 mRNA	19p13.3	A21035
Entinostat	Investigational	GNG8	94235	upregulated	entinostat results in increased expression of GNG8 mRNA	19q13.32	A21035
Entinostat	Investigational	GNGT1	2792	upregulated	entinostat results in increased expression of GNGT1 mRNA	7q21.3	A21035
Entinostat	Investigational	GOLGA1	2800	downregulated	entinostat results in decreased expression of GOLGA1 mRNA	9q33.3	A21037
Entinostat	Investigational	GOLGA8H	728498	upregulated	entinostat results in increased expression of GOLGA8H mRNA	15q13.2	A21035
Entinostat	Investigational	GPATCH2	55105	downregulated	entinostat results in decreased expression of GPATCH2 mRNA	1q41	A21037
Entinostat	Investigational	GPATCH2	55105	upregulated	entinostat results in increased expression of GPATCH2 mRNA	1q41	A21035
Entinostat	Investigational	GPC3	2719	downregulated	entinostat results in decreased expression of GPC3 mRNA	Xq26.2	A21037
Entinostat	Investigational	GPC3	2719	upregulated	entinostat results in increased expression of GPC3 mRNA	Xq26.2	A21035
Entinostat	Investigational	GPC6	10082	downregulated	entinostat results in decreased expression of GPC6 mRNA	13q31.3-q32.1	A21037
Entinostat	Investigational	GPD1L	23171	upregulated	entinostat results in increased expression of GPD1L mRNA	3p22.3	A21037
Entinostat	Investigational	GPHA2	170589	upregulated	entinostat results in increased expression of GPHA2 mRNA	11q13.1	A21037
Entinostat	Investigational	GPM6A	2823	upregulated	entinostat results in increased expression of GPM6A mRNA	4q34.2	A21037
Entinostat	Investigational	GPM6B	2824	upregulated	entinostat results in increased expression of GPM6B mRNA	Xp22.2	A21037
Entinostat	Investigational	GPR143	4935	upregulated	entinostat results in increased expression of GPR143 mRNA	Xp22.2	A21037
Entinostat	Investigational	GPR155	151556	upregulated	entinostat results in increased expression of GPR155 mRNA	2q31.1	A21035
Entinostat	Investigational	GPR157	80045	upregulated	entinostat results in increased expression of GPR157 mRNA	1p36.22	A21035
Entinostat	Investigational	GPR160	26996	upregulated	entinostat results in increased expression of GPR160 mRNA	3q26.2	A21037
Entinostat	Investigational	GPR161	23432	downregulated	entinostat results in decreased expression of GPR161 mRNA	1q24.2	A21037
Entinostat	Investigational	GPR173	54328	downregulated	entinostat results in decreased expression of GPR173 mRNA	Xp11.22	A21037
Entinostat	Investigational	GPR176	11245	upregulated	entinostat results in increased expression of GPR176 mRNA	15q14-q15.1	A21035
Entinostat	Investigational	GPR22	2845	downregulated	entinostat results in decreased expression of GPR22 mRNA	7q22.3	A21035
Entinostat	Investigational	GPRC5A	9052	upregulated	entinostat results in increased expression of GPRC5A mRNA	12p13.1	A21035

Displaying entries 37326 - 37350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability